Bruker Corp (BRKRP) stock
BRKRPNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKR
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30308% above fair value
$457.73+12.62 (+2.84%)
Close on Nov 18, 2026Market cap $9.81BP/E –Yield –
Bruker revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Bruker's revenue for the twelve months ending Jun 30, 2026 was $3.50B, up 1.6% year over year. For fiscal 2025 it was $3.44B, up 2.1% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is $3.44B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.44B | +2.1% |
| FY2024 | Dec 31, 2024 | $3.37B | +13.6% |
| FY2023 | Dec 31, 2023 | $2.96B | +17.1% |
| FY2022 | Dec 31, 2022 | $2.53B | +4.7% |
| FY2021 | Dec 31, 2021 | $2.42B | +21.7% |
| FY2020 | Dec 31, 2020 | $1.99B | -4.1% |
| FY2019 | Dec 31, 2019 | $2.07B | +9.3% |
| FY2018 | Dec 31, 2018 | $1.90B | +7.3% |
| FY2017 | Dec 31, 2017 | $1.77B | +9.6% |
| FY2016 | Dec 31, 2016 | $1.61B | -0.8% |
| FY2015 | Dec 31, 2015 | $1.62B | -10.2% |
| FY2014 | Dec 31, 2014 | $1.81B | -1.7% |
| FY2013 | Dec 31, 2013 | $1.84B | +2.7% |
| FY2012 | Dec 31, 2012 | $1.79B | +8.5% |
| FY2011 | Dec 31, 2011 | $1.65B | +26.6% |
| FY2010 | Dec 31, 2010 | $1.30B | +17.1% |
| FY2009 | Dec 31, 2009 | $1.11B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $838.50M | +5.2% |
| Q1 FY2026 | Mar 31, 2026 | $823.40M | +2.7% |
| Q4 FY2025 | Dec 31, 2025 | $977.20M | -0.2% |
| Q3 FY2025 | Sep 30, 2025 | $860.50M | -0.5% |
| Q2 FY2025 | Jun 30, 2025 | $797.40M | -0.4% |
| Q1 FY2025 | Mar 31, 2025 | $801.40M | +11.0% |
| Q4 FY2024 | Dec 31, 2024 | $979.60M | +14.6% |
| Q3 FY2024 | Sep 30, 2024 | $864.40M | +16.4% |
| Q2 FY2024 | Jun 30, 2024 | $800.70M | +17.4% |
| Q1 FY2024 | Mar 31, 2024 | $721.70M | +5.3% |
| Q4 FY2023 | Dec 31, 2023 | $854.50M | +20.6% |
| Q3 FY2023 | Sep 30, 2023 | $742.80M | +16.3% |
| Q2 FY2023 | Jun 30, 2023 | $681.90M | +15.9% |
| Q1 FY2023 | Mar 31, 2023 | $685.30M | +15.2% |
| Q4 FY2022 | Dec 31, 2022 | $708.40M | +3.6% |
| Q3 FY2022 | Sep 30, 2022 | $638.90M | +4.9% |
| Q2 FY2022 | Jun 30, 2022 | $588.40M | +3.1% |
| Q1 FY2022 | Mar 31, 2022 | $595.00M | +7.3% |
| Q4 FY2021 | Dec 31, 2021 | $683.50M | +8.9% |
| Q3 FY2021 | Sep 30, 2021 | $608.90M | +19.1% |
| Q2 FY2021 | Jun 30, 2021 | $570.80M | +34.4% |
| Q1 FY2021 | Mar 31, 2021 | $554.70M | +30.8% |
| Q4 FY2020 | Dec 31, 2020 | $627.50M | +4.6% |
| Q3 FY2020 | Sep 30, 2020 | $511.40M | -1.9% |
| Q2 FY2020 | Jun 30, 2020 | $424.60M | -13.4% |
| Q1 FY2020 | Mar 31, 2020 | $424.00M | -8.1% |
| Q4 FY2019 | Dec 31, 2019 | $599.90M | +8.4% |
| Q3 FY2019 | Sep 30, 2019 | $521.10M | +11.7% |
| Q2 FY2019 | Jun 30, 2019 | $490.20M | +10.5% |
| Q1 FY2019 | Mar 31, 2019 | $461.40M | +6.9% |
| Q4 FY2018 | Dec 31, 2018 | $553.60M | +4.4% |
| Q3 FY2018 | Sep 30, 2018 | $466.60M | +7.1% |
| Q2 FY2018 | Jun 30, 2018 | $443.70M | +6.9% |
| Q1 FY2018 | Mar 31, 2018 | $431.70M | +12.2% |
| Q4 FY2017 | Dec 31, 2017 | $530.50M | +12.8% |
| Q3 FY2017 | Sep 30, 2017 | $435.60M | +10.6% |
| Q2 FY2017 | Jun 30, 2017 | $414.90M | – |
| Q1 FY2017 | Mar 31, 2017 | $384.90M | – |
| Q4 FY2016 | Dec 31, 2016 | $470.30M | – |
| Q3 FY2016 | Sep 30, 2016 | $393.90M | – |
See a number that looks wrong?